Cargando…
Determinants of morbidities and mortality in acromegaly
Acromegaly is a systemic disease associated with increased morbidity, presenting cardiovascular, metabolic, respiratory, neoplastic, endocrine, articular and bone complications. Most of these comorbidities can be prevented or delayed with adequate disease treatment and, more recent studies with the...
Autores principales: | Kasuki, Leandro, Rocha, Paula da Silva, Lamback, Elisa Baranski, Gadelha, Mônica Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522229/ https://www.ncbi.nlm.nih.gov/pubmed/31939488 http://dx.doi.org/10.20945/2359-3997000000193 |
Ejemplares similares
-
MicroRNA in Acromegaly: Involvement in the Pathogenesis and in the Response to First-Generation Somatostatin Receptor Ligands
por: Henriques, Daniel G., et al.
Publicado: (2022) -
Novel therapies for acromegaly
por: Maia, Bernardo, et al.
Publicado: (2020) -
The genetic background of acromegaly
por: Gadelha, Mônica R., et al.
Publicado: (2017) -
The Future of Somatostatin Receptor Ligands in Acromegaly
por: Gadelha, Monica R, et al.
Publicado: (2021) -
Acromegaly and Colorectal Neoplasm: An Update
por: Kasuki, Leandro, et al.
Publicado: (2022)